Pain Management in Patients with Opioid Use Disorders
|
|
- Ross Horton
- 8 years ago
- Views:
Transcription
1 4:30 p.m. - 5:15 p.m. Pain Management in Patients with Opioid Use Disorders Aleksandra Zgierska, MD, PhD Assistant Professor, University of Wisconsin-Madison Department of Family Medicine and Community Health Center for Addictive Disorders
2 Pain Management in Patients with Opioid Use Disorders Aleksandra Zgierska, MD PhD UW-Madison School of Medicine & Public Health Department of Family Medicine, Center for Addictive Disorders, Program for Pain and Opioid Education, Therapy and Studies ICOO 2015 Jun 8, 2015, Boston, MA Disclosure: I have no conflict of interest Objectives Opioid use disorders (OUDs) Medication-assisted treatments (MATs) for opioid addiction Treating pain in patients with OUDs Legal aspects of addiction-related care Discussion Papaver somniferum Wikimedia Creative Commons 1
3 Opioid addiction & pain: main points Opioid addiction is a chronic disease that overlaps with pain conditions MATs: effective public health strategy for reducing harms of opioid addiction Pain should be treated in opioid-addicted patients; if long-term opioids are needed, the treatment and monitoring plan should be appropriately adjusted What is Opioid Addiction? Addiction: most severe disorder Addiction Abuse A Public Health Approach to Drug Control in Canada Health Officers Council of British Columbia, October
4 What is Addiction? Am Society Addiction Medicine 2011 Addiction = opioid dependence primary chronic brain disease affecting multiple brain circuits adverse effects on mental and physical health interactions with pain-related circuitry hallmark symptom: loss of control over drug use in spite of harm addicere [in Latin]: to give over, dedicate or surrender What is Addiction? Am Society Addiction Medicine 2011 unless treated, addiction is progressive, can lead to disability and premature death. Question 1 J.S. is a 45 yo man with CLBP, on OxyContin 40 mg BID. He lost tablets when travelling and is calling for an early refill. He reports sweats, diarrhea, anxiety. His record / history: negative for addictive behaviors. Based on this information, J.S. meets criteria for: A. Opioid addiction B. Physical dependence C. Pseudo-addiction D. Neither 3
5 Medication Assisted Treatments (MATs) for Opioid Addiction Wiki Commons, Papaver somniferum Addiction is treatable.if the patient receives treatment chronic disease model long-term (often lifetime) treatment more treatment = better outcomes multidisciplinary approach address comorbidities pain, mental health, sleep problems Saitz R et al. J Addict Med 2008; 2:55 65 Addiction is treatable: treatment outcomes at 6-12 months Opioid Addiction Alcoholism 50-80% abstinent 50-70% abstinent Diabetes Type % good control < 50 % are compliant with medications Hypertension, asthma 20-50% good control < 30 % are compliant with medications O Brien CP & McLellan AT, Lancet
6 MAT for Opioid Dependence Methadone (only licensed programs) full agonist of µ receptors 1-2 x/day PO; half-life: (mean 22) hours Buprenorphine (any certified physician) partial agonist of µ, antagonist of κ receptors 1 x/day SL; half-life: (mean 37) hours Naltrexone (any clinician) Antagonist of µ receptors 1 x/day PO; monthly IM MAT for Opioid Addiction improves individual and societal outcomes enables patients to re-integrate into the society and live productive normal lives Mattick RP, Cochrane 2009; Soyka M, World J Biol Psych 2011; Connock M, Health Technol Assess 2007; Syed YY, CNS Drugs 2013; Krupitsky E, Addiction 2013; Hartung DM, J Subst Abuse Treat 2014 MAT treates Opioid Addiction drug use deaths criminal activity risk / spread of HIV cost retention-in-treatment engagement in work / social roles pregnancy / child outcomes Mattick RP, Cochrane 2009; Soyka M, World J Biol Psych 2011; Connock M, Health Technol Assess 2007; Syed YY, CNS Drugs 2013; Krupitsky E, Addiction 2013; Hartung DM, J Subst Abuse Treat
7 Methadone maintenance Wiki Commons, SubDural12: Methadone spacefill Methadone maintenance licensed programs only Methadone compared to other opioids: long-acting fat-soluble variable metabolism rates ( fast metabolizers ) risk of respiratory depression risk when used with EtOH or benzodiazepines QTc prolongation concerns Buprenorphine maintenance Wiki Commons, Jynto: Buprenorphine molecule 6
8 Buprenorphine maintenance any certified physician Buprenorphine compared to other opioids: similar withdrawal agonist analgesic effects may have efficacy for neuropathic pain, constipation, hyperalgesia, hormonal problems less respiratory depression (ceiling effect) risk when used with EtOH or benzodiazepines Buprenorphine for pain can be prescribed by ANY provider as Butrans patches Wiki Commons, 9ballguy, Butrans10mcg Buprenorphine for addiction can be prescribed by certified physicians only (special X DEA is required) certification: 8-hr online course (CME credit) buprenorphine.samhsa. gov/training_main.html Wiki Commons, Jr de Barbosa, Suboxone SL Tabs 7
9 Buprenorphine for addiction usually once/day dosing can be flexible if the patient takes it at home primarily prescribed as a combo of buprenorphine and naloxone deterrent against IV abuse Suboxone = buprenorphine + naloxone Subutex = buprenorphine Buprenorphine for addiction Induction at the clinic: patient in moderate withdrawal high-affinity for μ receptor: precipitates withdrawal if other opioids are still on board supervised initiation, incremental dosing Avoid (when possible) temporary switching of bupe to a different opioid the patient will need to be re-induced again when re-starting bupe Naltrexone maintenance Wiki Commons, Benjahbmm27, Naltrexone 3D balls 8
10 Naltrexone Maintenance Blocks opioid receptors can t get high removes pleasure of using drugs No diversion, non-addictive no withdrawal FDA-approved for both opioid and alcohol addiction Naltrexone maintenance Difficult to initiate in out-patient settings requires several days off opioids discomfort of acute withdrawal relapse Patient concerns: Does it work? What if I need pain medications..? Question 2 B.C. is a 72 yo woman with chronic neck pain and a remote h/o opioid addiction, now in recovery. Existing treatments were not effective, and you ve decided to start a trial of long-term opioid therapy. What is the best opioid choice for her? A. Fentanyl B. Buprenorphine C. Methadone D. Either B or C 9
11 Treating Pain in Patients with Opioid Use Disorders Papaver somniferum Wikimedia Creative Commons Addiction Pain Interactions Treatment of pain is the basic human right including among those with opioid addiction Wiki Commons, Vincent van Gogh, Sorrowing Old Man Addiction Pain Interactions uncontrolled pain: worse outcomes in addiction risk factor for continued use and relapse clinical challenge: distinguishing addiction from undertreated pain Wiki Commons, Vincent van Gogh, Sorrowing Old Man 10
12 Opioids for acute pain evidence-based for severe acute pain not controversial unless the patient has a history of or a current addiction especially to opioids on the maintenance treatment acute severe pain should be treated regardless of addiction Opioids for acute pain in opioid addiction Expect needing higher opioid doses (due to tolerance) in those with active opioid addiction opioid maintenance therapy opioid-treated chronic pain Opioids for acute pain in opioid addiction Methadone maintenance patients: add additional opioids Naltrexone maintenance patients: non-opioid analgesics; tramadol can override the blockade using higherdoses of opioids monitored settings monitor vitals, especially respiratory status 11
13 Opioids for acute pain in opioid addiction Buprenorphine maintenance patients non-opioid analgesics; tramadol increase bupe dose continue bupe, add regular opioids higher doses of opioids are expected no need to stop bupe for small surgeries if stopped, it is hard to re-start it Opioid therapy for chronic pain Controversial for non-cancer pain lack of evidence on long-term efficacy dose-dependent adverse effects Chou R, AHRQ review of evidence, 2014 epidemic of prescription opioid abuse Opioid therapy for chronic pain in opioid addiction Initiate long-term opioids ONLY if the potential benefit outweighs the risk 12
14 Opioid therapy for chronic pain in opioid addiction Methadone maintenance patients once/day dosing (twice/day doses for fast metabolizers ) not adequate for pain control only methadone clinics can prescribe methadone for addiction Other opioids or extra methadone can be added to methadone prescribed for addiction Opioid therapy for chronic pain in opioid addiction Opioid-treated chronic pain patients with an active opioid addiction limited data suggest that rotating other opioids to methadone is superior to opioid discontinuation 1990 Kennedy JA, Crowley TJ, J Subst Abuse Treat, Tennant FS, Rawson RA, Arch Intern Med, 1982 Opioid therapy for chronic pain In opioid addiction Naltrexone maintenance patients stop naltrexone. IM naltrexone works for 1 month 13
15 Opioid therapy for chronic pain In opioid addiction Buprenorphine maintenance patients SL preparations are approved for addiction only can address pain with TID-QID dosing Malinoff HL, Am J Ther, 2005 patches are approved for pain only can address opioid addiction Opioid therapy for chronic pain in opioid addiction Opioid-treated chronic pain patients with an active opioid addiction limited data suggest that rotating other opioids to buprenorphine is superior to opioid discontinuation Blondell RD, J Addict Med, 2010 Chronic pain and addiction: special populations Pregnancy: avoid opioid withdrawal, as fetal abstinence syndrome can be fatal avoid partial agonists and antagonists bupe vs methadone: both can be used bupe may cause less neonatal withdrawal Minozzi S, Cochrane Database Sys Rev, 2013 Elderly: buprenorphine is the preferred opioid Consensus statement: Pergolozzi J, Pain Pract,
16 Opioid therapy for chronic pain in opioid addiction: practical considerations If long-term opioid therapy is needed: assess the risk (it s high!) and comorbidities to map out a comprehensive treatment plan strive to use one type of a long-acting opioid consider abuse-deterrent ones close monitoring detailed treatment agreement: discuss it up front frequent (random) urine drug testing, pill counts adherence to recommended other treatments Opioid therapy for chronic pain in opioid addiction: practical considerations Mental health / sleep co-morbidities limit # of sedating medications avoid benzos and z-drugs maximize SSRIs, pain modulating meds gabapentin often helpful monitor as it has some addictive potential fatigue, ADHD avoid stimulants consider atomoxetine Question 3 M.H. is a 36 yo woman with chronic pain, treated with Kadian 40 mg/day + morphine IR 15-30mg q4 hrs PRN. You discover she is actively abusing opioids, and recommend addiction treatment. She declines, noshows at the clinic, and gets Rx for opioids and benzos from the ED. Which approach would you choose? A. Switch to buprenorphine therapy B. Switch to methadone therapy C. Initiate slow opioid taper D. Discontinue opioids 15
17 Opioid discontinuation Primum non nocere if addiction, serious adverse effects, or diversion are suspected or documented, opioids may need to be discontinued Opioid discontinuation TAPER, if the patient contracts for safety develop a treatment plan taper ~25% a daily dose every 1-2 weeks close monitoring (short supply) STOP prescribing (abrupt cut-off) if it is not safe to gradually taper opioid withdrawal is unpleasant, but not fatal* * except in-utero, when it can be fatal Opioid withdrawal: treatment Clonidine (if BP / Pulse are OK) do not prescribe to unknown patients 0.1mg PO q 4-6 hours; tab, close F/U; if longer duration: consider taper Symptomatic care for anxiety, insomnia, aches, nausea, diarrhea, cramping, dehydration ibuprofen, tylenol, dicyclomine, loperamide, anti-emetics, heating pad gabapentin, trazodone, etc, but avoid benzos 16
18 Legal Aspects Relevant to the Treatment of Opioid Addiction Wiki Commons, Papaver somniferum Legal Aspects of Addiction Care It is illegal to treat opioid addiction or withdrawal with an opioid unless it s methadone in a licensed program or buprenorphine prescribed by a certified physician Legal Aspects of Addiction Care Patient can be discharged from practice - 30 day notice letter (need to provide care for 30 days) - have clear guidelines - have good documentation Engage Patient Resources opioid therapy termination discharge from practice 17
19 Conclusions Opioid addiction is a chronic disease that overlaps with pain conditions MATs: effective public health strategy for reducing harms of opioid addiction Pain should be treated in opioid-addicted patients; if long-term opioids are needed, the treatment and monitoring plan should be appropriately adjusted Additional resources screening tools exist to assess the risk of opioid therapy comprehensive resource: OpioidRisk site Additional resources Pain and addiction (ASAM) The Medication Guide for a Safe Recovery by PH Earley NIDA Fact Sheets on substance abuse, current concepts & emerging trends search for a desired topic 18
20 Thank you! 19
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationFinancial Disclosures
Opioid Agonist Therapy: To Maintain or Not To Maintain - A Case Discussion PCSS-MAT American Psychiatric Association Drs. Ed Salsitz, John Renner, Timothy Fong April 14, 2015 Financial Disclosures Edwin
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationTreatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
More informationOPIOIDS. Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School
OPIOIDS Petros Levounis, MD, MA Chair Department of Psychiatry Rutgers New Jersey Medical School Rutgers New Jersey Medical School Fundamentals of Addiction Medicine Summer Series Newark, NJ July 24, 2013
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2011 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationOpioids Research to Practice
Opioids Research to Practice CRIT/FIT 2015 May 2015 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationOpioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015
Q: I have read 40 mg of methadone stops withdrawal, so why don t we start at 30mg and maybe later in the day add 10mg? A: Federal Regulations stipulate that 30mg is the maximum first dose in an Opioid
More informationProgram Assistance Letter
Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care
More informationUsing Buprenorphine to Treat Acute Opioid Withdrawal in the ED
Using Buprenorphine to Treat Acute Opioid Withdrawal in the ED Dr. Karine Meador MD CCFP DABAM Assistant Director Inner City Health and Wellness Team Physician Addiction Recovery and Community Health (ARCH)
More informationNon medical use of prescription medicines existing WHO advice
Non medical use of prescription medicines existing WHO advice Nicolas Clark Management of Substance Abuse Team WHO, Geneva Vienna, June 2010 clarkn@who.int Medical and Pharmaceutical role Recommendations
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationAssessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in
More informationManaging drug-seeking behavior
Managing drug-seeking behavior Miriam Komaromy, MD Medical Director UNM Project ECHO Addiction Treatment Program The $10,000 question Why is the patient seeking the drugs? The problem: Only the patient
More informationBuprenorphine: what is it & why use it?
Buprenorphine: what is it & why use it? Dr Nicholas Lintzeris, MBBS, PhD, FAChAM Locum Consultant, Oaks Resource Centre, SLAM National Addiction Centre, Institute of Psychiatry Overview of presentation
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationOpioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationPrimary Care Behavioral Interventions for Pain and Prescription Opioid Misuse
Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse J E F F R E I T E R, P H D, A B P P H E A L T H P O I N T C O M M U N I T Y H E A L T H C E N T E R S S P R I N G 2 0 1 3 A
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationUCLA-SAPC Lecture Series March 13, 2015. Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control
UCLA-SAPC Lecture Series March 13, 2015 Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control Neurobiology 101 Neuroscience of Addiction & Recovery Medication-Assisted Treatment (MAT)
More informationTriage, Assessment & Treatment Methadone 101/Hospitalist Workshop
Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop Launette Rieb, MSc, MD, CCFP, FCFP Clinical Associate Professor, Dept. Family Practice UBC American Board of Addiction Medicine Certified
More informationAcute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction
Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel
More informationAcute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC
Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationConceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationDidactic Series. Office-based Treatment for Substance Abuse Disorder in HIV-infected Patients. Jacqueline Tulsky, MD Pacific AETC June 26, 2014
Didactic Series Office-based Treatment for Substance Abuse Disorder in HIV-infected Patients Jacqueline Tulsky, MD Pacific AETC June 26, 2014 ACCREDITATION STATEMENT: University of California, San Diego
More informationTreatment of Opioid Addiction. Miriam Komaromy, MD Associate Director, Project ECHO University of New Mexico Health Sciences Center
Treatment of Opioid Addiction Miriam Komaromy, MD Associate Director, Project ECHO University of New Mexico Health Sciences Center Why does the human brain become addicted? Why can we only become addicted
More informationPutting Addiction Treatment Medications to Use: Lessons Learned
Putting Addiction Treatment Medications to Use: Lessons Learned George E. Woody, M.D. Laura McNicholas, M.D., Ph.D. Department of Psychiatry, University of Pennsylvania School of Medicine and Philadelphia
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationNaltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
More informationCOMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationPOST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics
POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationMEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model
MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT An Outpatient Model OBJECTIVE TO PRESENT A PROTOCOL FOR THE EVALUATION AND TREATMENT OF PATIENTS WHO ARE CHEMICALLY DEPENDENT ON OR SEVERLY
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationSUBOXONE for Opioid Addiction Medication Assisted Therapy. Dr. Jennifer Melamed MBChB, ABAM, CISAM, CCSAM
N SUBOXONE for Opioid Addiction Medication Assisted Therapy Dr. Jennifer Melamed MBChB, ABAM, CISAM, CCSAM CONTENTS Part 1 Introduction to N SUBOXONE Part 2 Pharmacology of N SUBOXONE Part 3 Pharmacokinetics
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationManaging prescription-opiate prescribing
Managing prescription-opiate prescribing Miriam Komaromy, MD Medical Director UNM Project ECHO Addiction Treatment Program And Turquoise Lodge Hospital, NM Department of Health Misuse of prescribed opioids
More informationSection Editor Andrew J Saxon, MD
Official reprint from UpToDate www.uptodate.com 2015 UpToDate Pharmacotherapy for opioid use disorder Author Eric Strain, MD Section Editor Andrew J Saxon, MD Deputy Editor Richard Hermann, MD All topics
More informationMEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT. POLICY NUMBER: 3.01.04 CATEGORY: Behavioral Health
MEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationGuidance for Disease Management in Correctional Settings OPIOID DETOXIFICATION
1145 W. Diversey Pkwy. 773-880-1460 Chicago, Illinois 60614 www.ncchc.org Guidance for Disease Management in Correctional Settings OPIOID DETOXIFICATION NCCHC issues guidance to assist correctional health
More informationGoals! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Addiction Vs! Dependence! The best laid If a tree falls!
Goals! Screening for Addiction and Dependence! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Implementing a Pain Contract! Narcotics & Pain Management in Addiction!
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationOpioid Replacement Therapy (ORT): Yes or No?
Opioid Replacement Therapy (ORT): Yes or No? Carl Christensen, MD, PhD, FASAM Associate Professor, Dept OB Gyn, WSU (retd) Medical Director, Addiction Medicine Services, DMC Past Chair, Michigan Health
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationPain Medication Taper Regimen Time frame to taper off 30-60 days
Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more
More informationTufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management
Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management June 10 and 11, 2011 Executive Summary Introduction Opioid
More informationUnderstanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders
Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationSAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
More informationMedications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal
Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH Alcohol Withdrawal MEDICATION Long/intermediateacting benzodiazepines (e.g., chlordiazepoxide/ Librium, diazepam/valium)
More informationCLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12
Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
More informationFederal Response to Opioid Abuse Epidemic
Healthcare Committee Federal Response to Opioid Abuse Epidemic On May 1, 20215 the Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled What is the Federal Government
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
More informationUNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
More informationCase Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist
Case Studies: Acute pain management in patients with opioid addiction Shannon Levesque, PharmD Clinical Pharmacist Disclosure I have no financial relationships with industry to disclose Objectives Misconceptions
More informationDosing Guide. For Optimal Management of Opioid Dependence
Dosing Guide For Optimal Management of Opioid Dependence KEY POINTS The goal of induction is to safely suppress opioid withdrawal as rapidly as possible with adequate doses of Suboxone (buprenorphine HCl/naloxone
More informationOpioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians
Opioid Dependence Treatment with Buprenorphine/Naloxone: An Overview for Pharmacists and Physicians Phyllis A. Grauer, PharmD, CGP, CPE Clinical Pharmacist Legislation Passed Enabling Office Based Treatment
More informationThe CCB Science 2 Service Distance Learning Program
S2S 2055 DETOXIFICATION Module 1 Post-Test 1. A common use of a biochemical marker is. a. to support or refute other information that leads to proper diagnosis b. for forensic purposes c. in detecting
More informationMedication treatments for opioid use disorders
Medication treatments for opioid use disorders Summary for counties JUDITH MARTIN, Medical Director of Substance Use Services, San Francisco Department of Public Health Brief history of Methadone and Buprenorphine
More informationGuidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
More informationSafely Discontinuing Opioid Analgesics
www.pain-topics.com Safely Discontinuing Opioid Analgesics Author: Editor: Medical Reviewer: Lee A. Kral, PharmD, BCPS Stewart B. Leavitt, MA, PhD Jeffrey Fudin, BS, PharmD, DAAPM Release Date: March 2006
More informationThis module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationPatients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
More informationAppendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids
More informationJoel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
More informationNALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder
More informationSELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC
SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationPrescription Medication Abuse: Skills for Prevention and Intervention
Prescription Medication Abuse: Skills for Prevention and Intervention icare Partnership www.icarenc.org James Finch, MD North Carolina Society of Addiction Medicine NC Governor s Institute on Alcohol and
More informationBlueprint for Prescriber Continuing Education Program
CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationTreatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
More informationTreating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest
Treating Addiction in Chronic Pain Patients A Clinical Journey Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest Pain Addiction Kaiser Permanente Northwest 480,000 members
More informationMedication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment
Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationU.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health
TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's
More information